Cronos Group - Common Share (CRON) closed at $3.41 on November 12, 2026, down 1.2% from the previous close, on volume of 905,147 shares (30-day average 1,021,440).
Data as of November 12, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 26, 2026 | Ratio Call Spread 1 by 2 | 21-Jan-283.5 : 5[2x] C | 6,000 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
Cronos Group Earnings Call Highlights Record Growth
TipRanks (Sun, 8-Nov 7:26 PM ET)
Cronos posts $17.1 million Adjusted EBITDA as Spinach holds Canada’s top vape and edible spots
Market Chameleon (Thu, 5-Nov 5:32 AM ET)
Cronos Group Reports 2026 Third Quarter Results
Globe Newswire (Thu, 5-Nov 7:30 AM ET)
Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company
Globe Newswire (Thu, 15-Oct 7:00 AM ET)
Globe Newswire (Tue, 13-Oct 7:30 AM ET)
Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026
Globe Newswire (Thu, 8-Oct 7:30 AM ET)
Cronos Hosts 2026 Investor Day
Globe Newswire (Thu, 24-Sep 8:00 AM ET)
Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario
Globe Newswire (Tue, 15-Sep 4:15 PM ET)
Cronos' brand Spinach Expands its Best-Selling Lineups of Edibles and Vapes
Globe Newswire (Wed, 2-Sep 7:30 AM ET)
Market Chameleon (Mon, 11-May 6:34 AM ET)
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
Cronos Group - Common Share trades on the NASDAQ stock market under the symbol CRON.
As of November 12, 2026, CRON stock price declined to $3.41 with 905,147 million shares trading.
CRON has a beta of 0.15, meaning it tends to be less sensitive to market movements. CRON has a correlation of 0.00 to the broad based SPY ETF.
CRON has a market cap of $1.25 billion. This is considered a Small Cap stock.
Last quarter Cronos Group - Common Share reported $63 million in Revenue and $.04 earnings per share. This fell short of revenue expectation by $-5 million and met earnings estimates .
In the last 3 years, CRON traded as high as $3.91 and as low as $1.60.
The top ETF exchange traded funds that CRON belongs to (by Net Assets): DFIS, DFIC, ONEQ, DFAX, GWX.
CRON has outperformed the market in the last year with a price return of +35.3% while the SPY ETF gained +12.0%. CRON has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +10.7% and +1.8%, respectively, while the SPY returned -1.5% and -2.0%, respectively.
CRON support price is $3.38 and resistance is $3.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRON shares will trade within this expected range on the day.
